Tijani Rasidat O, Molina-Tijeras Jose Alberto, Vezza Teresa, Ruiz-Malagón Antonio Jesús, Cádiz-Gurrea María de la Luz, Segura-Carretero Antonio, Abiodun Oyindamola O, Galvez Julio
Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria; Department of Pharmaceutical Technology, Moshood Abiola Polytechnic, Ojere, Abeokuta, Nigeria.
CIBER-EHD, Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071, Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012, Granada, Spain.
J Ethnopharmacol. 2022 Jan 10;282:114651. doi: 10.1016/j.jep.2021.114651. Epub 2021 Sep 16.
Metabolic syndrome is currently recognized as the major cause of morbidity, with dramatic complications on life expectancy and health status. Myrianthus arboreus is a medicinal plant traditionally used in local communities as a safe remedy in treating diabetes and other metabolic diseases.
This study aimed to investigate the impact of a methanol extract of Myrianthus arboreus leaf (MAL) in a mice model of metabolic syndrome induced by a high-fat diet (HFD) intake.
Male C57BL/6J mice were assigned to the following groups: control, obese control, and obese treated with MAL extract (10, 25, and 50 mg/kg) for 6 weeks. Control mice received a standard chow diet, while all obese mice were fed with HFD. Animal weight and food consumption were periodically measured. At the end of the treatment, fasting blood glucose and metabolic plasma analysis (insulin level, triglycerides, and total cholesterol (TC)) were performed. The HFD-induced inflammatory status and the expression of several obesity-related markers were evaluated in liver and fat using qPCR and Western blot analysis. In addition, the phytochemical composition of MAL was identified by GC-MS and HPLC-MS.
MAL administration significantly reduced body weight gain, basal glycemia, and insulin resistance, and improved plasma lipid profile compared with HFD-fed mice. Similarly, this extract improved the HFD-associated inflammatory status in mice by gene expression modulation of different inflammatory markers involved in this experimentally induced metabolic condition.
These results demonstrate the novel applicability of MAL, thus suggesting it as a promising therapeutic approach for the management of metabolic disorders.
代谢综合征目前被认为是发病的主要原因,对预期寿命和健康状况有严重并发症。多蕊木是一种药用植物,传统上在当地社区被用作治疗糖尿病和其他代谢疾病的安全药物。
本研究旨在调查多蕊木树叶甲醇提取物(MAL)对高脂饮食(HFD)诱导的代谢综合征小鼠模型的影响。
将雄性C57BL/6J小鼠分为以下几组:对照组、肥胖对照组和用MAL提取物(10、25和50mg/kg)治疗的肥胖组,持续6周。对照小鼠接受标准饲料饮食,而所有肥胖小鼠均喂食HFD。定期测量动物体重和食物消耗量。在治疗结束时,进行空腹血糖和代谢血浆分析(胰岛素水平、甘油三酯和总胆固醇(TC))。使用qPCR和蛋白质印迹分析评估HFD诱导的炎症状态以及几种肥胖相关标志物在肝脏和脂肪中的表达。此外,通过气相色谱-质谱联用(GC-MS)和高效液相色谱-质谱联用(HPLC-MS)鉴定MAL的植物化学成分。
与喂食HFD的小鼠相比,给予MAL可显著降低体重增加、基础血糖和胰岛素抵抗,并改善血脂谱。同样,该提取物通过调节参与这种实验诱导的代谢状况的不同炎症标志物的基因表达,改善了小鼠中与HFD相关的炎症状态。
这些结果证明了MAL的新适用性,因此表明它是一种有前途的治疗代谢紊乱的方法。